Skip to content

Robot-Assisted Sacrocolpopexy Using Autologous Posterior Rectus Sheath Restore Vaginal Support: The RESTORE Study

Evaluating the use of Robot-Assisted Sacrocolpopexy Using Autologous Posterior Rectus Sheath Restore Vaginal Support on pelvic organ positioning in adults with pelvic organ prolapse: The RESTORE Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000496314
Acronym
The RESTORE Study
Enrollment
40
Registered
2026-04-22
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Pelvic organ prolapse (POP) is a common condition affecting women, with vaginal childbirth. Sacral colpopexy is considered the gold standard operation for prolapse of the vaginal apex and can be performed via open, laparoscopic, or robot-assisted approaches, with comparable efficacy across access methods. A graft is used to suspend the vaginal apex from the sacral promontory. Graft options for the treatment of Pelvic Organ Prolapse have been Synthetic mesh - no longer approved for use by the TGA and Autologous fascia lata. Autologous Fascia Lata harvest requires an additional operative site, which may be associated with donor site morbidity such as pain, scarring, and delayed wound healing. Posterior rectus sheath (PRS) represents a novel alternative autologous graft that may mitigate these limitations. As a local abdominal fascial tissue, PRS can be harvested from the same operative field used for sacrocolpopexy, This study will describe the surgical techniques of robotic autologous posterior rectus sheath sacral colpopexy (PRS-AC) for bothersome apical prolapse and report 1-year anatomic and functional outcome

Interventions

Robot-assisted sacrocolpopexy using posterior rectus sheath (PRS) a novel alternative autologous graft for the treatment of pelvic organ prolapse. Harvested from local abdominal fascial tissue, PRS can be harvested from the same operative field used for sacrocolpopexy, eliminating the need for a separate thigh incision. The procedure will be completed in a single surgical session lasting approximately 90 minutes. All participating surgeons are suitably trained and proficient in performing POP-Q

Robot-assisted sacrocolpopexy using posterior rectus sheath (PRS) a novel alternative autologous graft for the treatment of pelvic organ prolapse. Harvested from local abdominal fascial tissue, PRS can be harvested from the same operative field used for sacrocolpopexy, eliminating the need for a separate thigh incision. The procedure will be completed in a single surgical session lasting approximately 90 minutes. All participating surgeons are suitably trained and proficient in performing POP-Q examination, robotic sacral colpopexy and posterior rectus sheath harvesting. The participating surgeons will receive standardised training in harvesting and PRS and placement of the graft onto the vagina. This training will involve direct observation of one case performed by the principal investigator. Following the observed case, the participating surgeon will perform three cases under the direct supervision of the principal investigator.

Sponsors

Epworth HealthCare
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Women 18 years old or older. • Consecutive women with greater than or stage 2 vaginal vault or uterine prolapse • Women that are able to comprehend and complete the study material

Exclusion criteria

• Women undergoing prolapse surgery who are unwilling or unable to participate in the study • Women who are unwilling or unable to give competent informed consent or unable to complete study questionnaires • Uterine abnormalities that exclude participation for subjects undergoing a sub-total hysterectomy are: o Abnormal endometrial thickness or sampling o Current or recent cervical dysplasia o Abnormal menstrual bleeding o Post-menopausal bleeding • High risk for endometrial cancer o Hereditary Non-Polyposis Colorectal Cancer (Lynch Syndrome), BRCA 1&2 o Tamoxifen therapy • High risk for general anaesthesia and/or laparoscopic surgery

Outcome results

None listed

Source: ANZCTR · Data processed: May 1, 2026